0001179110-16-022590.txt : 20160401
0001179110-16-022590.hdr.sgml : 20160401
20160401195221
ACCESSION NUMBER: 0001179110-16-022590
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160401
FILED AS OF DATE: 20160401
DATE AS OF CHANGE: 20160401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001467652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270395455
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
BUSINESS PHONE: 972.408.1360
MAIL ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Garg Vipin K
CENTRAL INDEX KEY: 0001515813
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37508
FILM NUMBER: 161548597
MAIL ADDRESS:
STREET 1: 4819 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
edgar.xml
FORM 4 -
X0306
4
2016-04-01
0
0001467652
Neos Therapeutics, Inc.
NEOS
0001515813
Garg Vipin K
C/O NEOS THERAPEUTICS, INC.
2940 N. HIGHWAY 360
GRAND PRAIRIE
TX
75050
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
10.74
2016-04-01
4
A
0
100000
0
A
2026-04-01
Common Stock
100000
100000
D
25,000 shares underlying this stock option vest in four equal, annual installments beginning on April 1, 2017. 75,000 shares underlying this stock option vest in four equal, annual installments beginning on April 1, 2017, provided that certain performance-based metrics have been met or satisfied on or before September 30, 2016.
/s/ Benjamin Piper, attorney-in-fact
2016-04-01